Researchers & Labs

researcher image '이병훈'

이병훈

Lee, Byung-Hoon

Department of New Biology

 학력

  • 1999 ~ 2004University of Texas Southwestern Medical Center 박사
  • 1996 ~ 1998서울대학교 석사
  • 1990 ~ 1996서울대학교 학사

 경력

  • 2016 ~ CurrentDGIST / Assistant Professor
  • 2018 ~ 2020Ubix Therapeutics / Scientific Advisory Board
  • 2007 ~ 2016Havard Medical Center / 박사후연구원
  • 2011 ~ 2011Proteostasis Therapeutics Inc / Scientific consultant
  • 2006 ~ 2007MIT / 박사후연구원

 수상실적

  • 2020 공로상 / DGIST
  • 2018 IUBMB YSP Fellowship / IUBMB-KSBMB
  • 2016 KSMCB International Conference Travel Grant Awards / 한국분자세포생물학회
  • 2004 Alfred Gilman Award / Univ. of Texas - Southwestern Medical Center at Dallas Southwestern Graduate School of Biomedic Sci.
  • 2001 American Diabetes Association Internship Award / Univ. of Texas - Southwestern Medical Center at Dallas Southwestern Graduate School of Biomedic Sci.

연구실 소개

Lab of Protein Homeostasis and Drug Discovery

Lab of Protein Homeostasis and Drug Discovery cover image

Protein homeostasis through the ubiquitin-proteasome system (UPS) is critical in almost every aspect of basic and clinical biology. Our lab is particularly interested in understanding cellular protein quality control system and developing the strategies for improving proteostasis by manipulating the UPS. We will primarily investigate critical deubiquitination machinery in human pathophysiology. Our group will try to develop functional and chemical strategies to modulate the deubiquitination activities on the proteasome and at the upstream of proteasome to explore novel biological mechanisms in the ubiquitin-proteasome pathways. By developing new DUB inhibitors, we aim to define novel drug targets in protein quality control machinery and ultimately seek for potential therapeutic strategies for human health.
1. Discovery of novel deconjugation mechanisms in the ubiquitin-proteasome pathways for cell physiology2. Investigation of novel regulatory mechanisms in ubiquitin deconjugation activities for proteasome function3. Defining deubiquitinating enzymes as novel drug targets in oncogenesis and other human diseases by functional and chemical studies4. Defining proteasome and deubiquitinating enzymes as novel drug targets in human longevity by combinatorial approaches of chemical and functional studies